Roundtable Discussion – Analyzing Approaches to Limit On-Target / Off-Tumor Toxicities of ADCs

Time: 11:30 am
day: Day Two


  • Following the previous talk, we will now look at how the community is thinking about on-target, off-tumor toxicities at the moment?
  • Evaluating to what extent on-target, off-tumor toxicities impact go/no-go decisions during ADC development
  • What challenges have people experienced in quantifying on-target, off-tumor toxicities?